Clinical Research Facility

Worchester, Massachusetts 01655

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Non Small Cell Lung Cancer (NSCLC) Clinical Trial
Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Status: Enrolling, Phase II, III
Updated: 1/14/2015
Clinical Research Facility
mi
from
Worchester, MA
Click here to add this to my saved trials